Global Peptide Vaccine Sales Market Report 2017

ペプチドワクチンの世界市場2017

◆タイトル:Global Peptide Vaccine Sales Market Report 2017
◆商品コード:QYR70301697
◆調査・発行会社:QYResearch
◆発行日:2017年2月20日
◆ページ数:110
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥872,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、ペプチドワクチンの世界市場について調査・分析し、ペプチドワクチンのメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、ペプチドワクチン産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・ペプチドワクチン市場概要
・ペプチドワクチンのメーカー別販売量・メーカー別シェア
・ペプチドワクチンの世界市場:種類別販売量・市場シェア
・ペプチドワクチンの世界市場:用途別販売量・市場シェア
・ペプチドワクチンの世界市場:地域別販売量・市場シェア
・ペプチドワクチンのアメリカ市場規模
・ペプチドワクチンの中国市場規模
・ペプチドワクチンのヨーロッパ市場規模
・ペプチドワクチンの日本市場規模
・ペプチドワクチンの東南アジア市場規模
・ペプチドワクチンのインド市場規模
・ペプチドワクチンのメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・ペプチドワクチンのコスト分析・価格動向
・ペプチドワクチンの産業チェーン(サプライチェーン分析)
・ペプチドワクチンのマーケティング戦略・販売チャネル、流通業者
・ペプチドワクチン市場への影響要因分析
・ペプチドワクチンの世界市場予測
・ペプチドワクチンのアメリカ市場予測
・ペプチドワクチンの中国市場予測
・ペプチドワクチンのヨーロッパ市場予測
・ペプチドワクチンの日本市場予測
・ペプチドワクチンの東南アジア市場予測
・ペプチドワクチンのインド市場予測
・ペプチドワクチンの種類別世界市場予測
・ペプチドワクチンの用途別世界市場予測
...

Notes:Sales, means the sales volume of Peptide Vaccine
Revenue, means the sales value of Peptide Vaccine

This report studies sales (consumption) of Peptide Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Artificial Cell Technologies
Benovus Bio
Bionor Pharma
Circassia
Celgene Corporation
Galena Biopharma
Immatics biotechnologies
Immune Design
ImmunoCellular Therapeutics
Invectys
ISA Pharmaceuticals
Lytix Biopharma
Medinet
Memcine Pharmaceuticals
Merck Serono
OncoTherapy Science

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Peptide Vaccine in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Peptide Vaccine in each application, can be divided into
Application 1
Application 2

【レポートの目次】

Table of Contents

Global Peptide Vaccine Sales Market Report 2017
1 Peptide Vaccine Overview
1.1 Product Overview and Scope of Peptide Vaccine
1.2 Classification of Peptide Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Peptide Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 Peptide Vaccine Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Peptide Vaccine (2012-2022)
1.5.1 Global Peptide Vaccine Sales and Growth Rate (2012-2022)
1.5.2 Global Peptide Vaccine Revenue and Growth Rate (2012-2022)

2 Global Peptide Vaccine Competition by Manufacturers, Type and Application
2.1 Global Peptide Vaccine Market Competition by Manufacturers
2.1.1 Global Peptide Vaccine Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Peptide Vaccine Revenue and Share by Manufacturers (2012-2017)
2.2 Global Peptide Vaccine (Volume and Value) by Type
2.2.1 Global Peptide Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 Global Peptide Vaccine Revenue and Market Share by Type (2012-2017)
2.3 Global Peptide Vaccine (Volume and Value) by Regions
2.3.1 Global Peptide Vaccine Sales and Market Share by Regions (2012-2017)
2.3.2 Global Peptide Vaccine Revenue and Market Share by Regions (2012-2017)
2.4 Global Peptide Vaccine (Volume) by Application

3 United States Peptide Vaccine (Volume, Value and Sales Price)
3.1 United States Peptide Vaccine Sales and Value (2012-2017)
3.1.1 United States Peptide Vaccine Sales and Growth Rate (2012-2017)
3.1.2 United States Peptide Vaccine Revenue and Growth Rate (2012-2017)
3.1.3 United States Peptide Vaccine Sales Price Trend (2012-2017)
3.2 United States Peptide Vaccine Sales and Market Share by Manufacturers
3.3 United States Peptide Vaccine Sales and Market Share by Type
3.4 United States Peptide Vaccine Sales and Market Share by Application

4 China Peptide Vaccine (Volume, Value and Sales Price)
4.1 China Peptide Vaccine Sales and Value (2012-2017)
4.1.1 China Peptide Vaccine Sales and Growth Rate (2012-2017)
4.1.2 China Peptide Vaccine Revenue and Growth Rate (2012-2017)
4.1.3 China Peptide Vaccine Sales Price Trend (2012-2017)
4.2 China Peptide Vaccine Sales and Market Share by Manufacturers
4.3 China Peptide Vaccine Sales and Market Share by Type
4.4 China Peptide Vaccine Sales and Market Share by Application

5 Europe Peptide Vaccine (Volume, Value and Sales Price)
5.1 Europe Peptide Vaccine Sales and Value (2012-2017)
5.1.1 Europe Peptide Vaccine Sales and Growth Rate (2012-2017)
5.1.2 Europe Peptide Vaccine Revenue and Growth Rate (2012-2017)
5.1.3 Europe Peptide Vaccine Sales Price Trend (2012-2017)
5.2 Europe Peptide Vaccine Sales and Market Share by Manufacturers
5.3 Europe Peptide Vaccine Sales and Market Share by Type
5.4 Europe Peptide Vaccine Sales and Market Share by Application

6 Japan Peptide Vaccine (Volume, Value and Sales Price)
6.1 Japan Peptide Vaccine Sales and Value (2012-2017)
6.1.1 Japan Peptide Vaccine Sales and Growth Rate (2012-2017)
6.1.2 Japan Peptide Vaccine Revenue and Growth Rate (2012-2017)
6.1.3 Japan Peptide Vaccine Sales Price Trend (2012-2017)
6.2 Japan Peptide Vaccine Sales and Market Share by Manufacturers
6.3 Japan Peptide Vaccine Sales and Market Share by Type
6.4 Japan Peptide Vaccine Sales and Market Share by Application
7 Southeast Asia Peptide Vaccine (Volume, Value and Sales Price)
7.1 Southeast Asia Peptide Vaccine Sales and Value (2012-2017)
7.1.1 Southeast Asia Peptide Vaccine Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Peptide Vaccine Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Peptide Vaccine Sales Price Trend (2012-2017)
7.2 Southeast Asia Peptide Vaccine Sales and Market Share by Manufacturers
7.3 Southeast Asia Peptide Vaccine Sales and Market Share by Type
7.4 Southeast Asia Peptide Vaccine Sales and Market Share by Application
8 India Peptide Vaccine (Volume, Value and Sales Price)
8.1 India Peptide Vaccine Sales and Value (2012-2017)
8.1.1 India Peptide Vaccine Sales and Growth Rate (2012-2017)
8.1.2 India Peptide Vaccine Revenue and Growth Rate (2012-2017)
8.1.3 India Peptide Vaccine Sales Price Trend (2012-2017)
8.2 India Peptide Vaccine Sales and Market Share by Manufacturers
8.3 India Peptide Vaccine Sales and Market Share by Type
8.4 India Peptide Vaccine Sales and Market Share by Application

9 Global Peptide Vaccine Manufacturers Analysis
9.1 Artificial Cell Technologies
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Peptide Vaccine Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Artificial Cell Technologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Benovus Bio
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Peptide Vaccine Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Benovus Bio Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Bionor Pharma
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Peptide Vaccine Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bionor Pharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Circassia
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Peptide Vaccine Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Circassia Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Celgene Corporation
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Peptide Vaccine Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Celgene Corporation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Galena Biopharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Peptide Vaccine Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Galena Biopharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Immatics biotechnologies
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Peptide Vaccine Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Immatics biotechnologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Immune Design
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Peptide Vaccine Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Immune Design Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 ImmunoCellular Therapeutics
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Peptide Vaccine Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Invectys
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Peptide Vaccine Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Invectys Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 ISA Pharmaceuticals
9.12 Lytix Biopharma
9.13 Medinet
9.14 Memcine Pharmaceuticals
9.15 Merck Serono
9.16 OncoTherapy Science

10 Peptide Vaccine Maufacturing Cost Analysis
10.1 Peptide Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Peptide Vaccine
10.3 Manufacturing Process Analysis of Peptide Vaccine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Peptide Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Peptide Vaccine Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Peptide Vaccine Market Forecast (2017-2022)
14.1 Global Peptide Vaccine Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Peptide Vaccine Price and Trend Forecast (2017-2022)
14.2 Global Peptide Vaccine Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Peptide Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Peptide Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Peptide Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Peptide Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Peptide Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Peptide Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Peptide Vaccine Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Peptide Vaccine Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Peptide Vaccine
Table Classification of Peptide Vaccine
Figure Global Sales Market Share of Peptide Vaccine by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Peptide Vaccine
Figure Global Sales Market Share of Peptide Vaccine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Peptide Vaccine Revenue and Growth Rate (2012-2022)
Figure China Peptide Vaccine Revenue and Growth Rate (2012-2022)
Figure Europe Peptide Vaccine Revenue and Growth Rate (2012-2022)
Figure Japan Peptide Vaccine Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Peptide Vaccine Revenue and Growth Rate (2012-2022)
Figure India Peptide Vaccine Revenue and Growth Rate (2012-2022)
Figure Global Peptide Vaccine Sales and Growth Rate (2012-2022)
Figure Global Peptide Vaccine Revenue and Growth Rate (2012-2022)
Table Global Peptide Vaccine Sales of Key Manufacturers (2012-2017)
Table Global Peptide Vaccine Sales Share by Manufacturers (2012-2017)
Figure 2015 Peptide Vaccine Sales Share by Manufacturers
Figure 2016 Peptide Vaccine Sales Share by Manufacturers
Table Global Peptide Vaccine Revenue by Manufacturers (2012-2017)
Table Global Peptide Vaccine Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Peptide Vaccine Revenue Share by Manufacturers
Table 2016 Global Peptide Vaccine Revenue Share by Manufacturers
Table Global Peptide Vaccine Sales and Market Share by Type (2012-2017)
Table Global Peptide Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Peptide Vaccine by Type (2012-2017)
Figure Global Peptide Vaccine Sales Growth Rate by Type (2012-2017)
Table Global Peptide Vaccine Revenue and Market Share by Type (2012-2017)
Table Global Peptide Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peptide Vaccine by Type (2012-2017)
Figure Global Peptide Vaccine Revenue Growth Rate by Type (2012-2017)
Table Global Peptide Vaccine Sales and Market Share by Regions (2012-2017)
Table Global Peptide Vaccine Sales Share by Regions (2012-2017)
Figure Sales Market Share of Peptide Vaccine by Regions (2012-2017)
Figure Global Peptide Vaccine Sales Growth Rate by Regions (2012-2017)
Table Global Peptide Vaccine Revenue and Market Share by Regions (2012-2017)
Table Global Peptide Vaccine Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Peptide Vaccine by Regions (2012-2017)
Figure Global Peptide Vaccine Revenue Growth Rate by Regions (2012-2017)
Table Global Peptide Vaccine Sales and Market Share by Application (2012-2017)
Table Global Peptide Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Peptide Vaccine by Application (2012-2017)
Figure Global Peptide Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Peptide Vaccine Sales and Growth Rate (2012-2017)
Figure United States Peptide Vaccine Revenue and Growth Rate (2012-2017)
Figure United States Peptide Vaccine Sales Price Trend (2012-2017)
Table United States Peptide Vaccine Sales by Manufacturers (2012-2017)
Table United States Peptide Vaccine Market Share by Manufacturers (2012-2017)
Table United States Peptide Vaccine Sales by Type (2012-2017)
Table United States Peptide Vaccine Market Share by Type (2012-2017)
Table United States Peptide Vaccine Sales by Application (2012-2017)
Table United States Peptide Vaccine Market Share by Application (2012-2017)
Figure China Peptide Vaccine Sales and Growth Rate (2012-2017)
Figure China Peptide Vaccine Revenue and Growth Rate (2012-2017)
Figure China Peptide Vaccine Sales Price Trend (2012-2017)
Table China Peptide Vaccine Sales by Manufacturers (2012-2017)
Table China Peptide Vaccine Market Share by Manufacturers (2012-2017)
Table China Peptide Vaccine Sales by Type (2012-2017)
Table China Peptide Vaccine Market Share by Type (2012-2017)
Table China Peptide Vaccine Sales by Application (2012-2017)
Table China Peptide Vaccine Market Share by Application (2012-2017)
Figure Europe Peptide Vaccine Sales and Growth Rate (2012-2017)
Figure Europe Peptide Vaccine Revenue and Growth Rate (2012-2017)
Figure Europe Peptide Vaccine Sales Price Trend (2012-2017)
Table Europe Peptide Vaccine Sales by Manufacturers (2012-2017)
Table Europe Peptide Vaccine Market Share by Manufacturers (2012-2017)
Table Europe Peptide Vaccine Sales by Type (2012-2017)
Table Europe Peptide Vaccine Market Share by Type (2012-2017)
Table Europe Peptide Vaccine Sales by Application (2012-2017)
Table Europe Peptide Vaccine Market Share by Application (2012-2017)
Figure Japan Peptide Vaccine Sales and Growth Rate (2012-2017)
Figure Japan Peptide Vaccine Revenue and Growth Rate (2012-2017)
Figure Japan Peptide Vaccine Sales Price Trend (2012-2017)
Table Japan Peptide Vaccine Sales by Manufacturers (2012-2017)
Table Japan Peptide Vaccine Market Share by Manufacturers (2012-2017)
Table Japan Peptide Vaccine Sales by Type (2012-2017)
Table Japan Peptide Vaccine Market Share by Type (2012-2017)
Table Japan Peptide Vaccine Sales by Application (2012-2017)
Table Japan Peptide Vaccine Market Share by Application (2012-2017)
Figure Southeast Asia Peptide Vaccine Sales and Growth Rate (2012-2017)
Figure Southeast Asia Peptide Vaccine Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Peptide Vaccine Sales Price Trend (2012-2017)
Table Southeast Asia Peptide Vaccine Sales by Manufacturers (2012-2017)
Table Southeast Asia Peptide Vaccine Market Share by Manufacturers (2012-2017)
Table Southeast Asia Peptide Vaccine Sales by Type (2012-2017)
Table Southeast Asia Peptide Vaccine Market Share by Type (2012-2017)
Table Southeast Asia Peptide Vaccine Sales by Application (2012-2017)
Table Southeast Asia Peptide Vaccine Market Share by Application (2012-2017)
Figure India Peptide Vaccine Sales and Growth Rate (2012-2017)
Figure India Peptide Vaccine Revenue and Growth Rate (2012-2017)
Figure India Peptide Vaccine Sales Price Trend (2012-2017)
Table India Peptide Vaccine Sales by Manufacturers (2012-2017)
Table India Peptide Vaccine Market Share by Manufacturers (2012-2017)
Table India Peptide Vaccine Sales by Type (2012-2017)
Table India Peptide Vaccine Market Share by Type (2012-2017)
Table India Peptide Vaccine Sales by Application (2012-2017)
Table India Peptide Vaccine Market Share by Application (2012-2017)
Table Artificial Cell Technologies Basic Information List
Table Artificial Cell Technologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Artificial Cell Technologies Peptide Vaccine Global Market Share (2012-2017)
Table Benovus Bio Basic Information List
Table Benovus Bio Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Benovus Bio Peptide Vaccine Global Market Share (2012-2017)
Table Bionor Pharma Basic Information List
Table Bionor Pharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bionor Pharma Peptide Vaccine Global Market Share (2012-2017)
Table Circassia Basic Information List
Table Circassia Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Circassia Peptide Vaccine Global Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgene Corporation Peptide Vaccine Global Market Share (2012-2017)
Table Galena Biopharma Basic Information List
Table Galena Biopharma Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galena Biopharma Peptide Vaccine Global Market Share (2012-2017)
Table Immatics biotechnologies Basic Information List
Table Immatics biotechnologies Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immatics biotechnologies Peptide Vaccine Global Market Share (2012-2017)
Table Immune Design Basic Information List
Table Immune Design Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immune Design Peptide Vaccine Global Market Share (2012-2017)
Table ImmunoCellular Therapeutics Basic Information List
Table ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure ImmunoCellular Therapeutics Peptide Vaccine Global Market Share (2012-2017)
Table Invectys Basic Information List
Table Invectys Peptide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Invectys Peptide Vaccine Global Market Share (2012-2017)
Table ISA Pharmaceuticals Basic Information List
Table Lytix Biopharma Basic Information List
Table Medinet Basic Information List
Table Memcine Pharmaceuticals Basic Information List
Table Merck Serono Basic Information List
Table OncoTherapy Science Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Vaccine
Figure Manufacturing Process Analysis of Peptide Vaccine
Figure Peptide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Peptide Vaccine Major Manufacturers in 2015
Table Major Buyers of Peptide Vaccine
Table Distributors/Traders List
Figure Global Peptide Vaccine Sales and Growth Rate Forecast (2017-2022)
Figure Global Peptide Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table Global Peptide Vaccine Sales Forecast by Regions (2017-2022)
Table Global Peptide Vaccine Sales Forecast by Type (2017-2022)
Table Global Peptide Vaccine Sales Forecast by Application (2017-2022)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ペプチドワクチンの世界市場2017] (Global Peptide Vaccine Sales Market Report 2017 / QYR70301697)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆